CytomX Therapeutics Inc
(FRA:6C1)
€
2.829
-0.042 (-1.46%)
Market Cap: 647.67 Mil
Enterprise Value: 345.02 Mil
PE Ratio: 0
PB Ratio: 2.23
GF Score: 36/100 CytomX Therapeutics Inc (FRA:6C1) Transcripts
- 1